Literature DB >> 8173915

Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus.

J D Roder1, R Busch, H J Stein, U Fink, J R Siewert.   

Abstract

Prognostic factors that may alter the indications for primary surgical resection or that can be influenced by the extent of the procedure were analysed in a homogeneous group of 186 patients with squamous cell carcinoma of the oesophagus. All patients underwent standardized en bloc oesophagectomy and lymph node dissection with prospective documentation of the histopathological findings; follow-up was complete. Multivariate analysis identified the Union Internacional Contra la Cancrum R category (i.e. the presence of residual tumour after resection) as the most important independent prognostic factor (P < 0.001) followed by the ratio of invaded to removed lymph nodes (P < 0.001). These data suggest that only patients in whom R0 resection can be anticipated based on preoperative assessment should undergo primary resection for oesophageal cancer. Extended lymphadenectomy may improve survival in patients with a limited number of invaded mediastinal nodes.

Entities:  

Mesh:

Year:  1994        PMID: 8173915     DOI: 10.1002/bjs.1800810330

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  49 in total

1.  Lymph Node Reaction to Cancer. (Immunohistochemical and Ultrastructural Study).

Authors:  Dmitry E Tsyplakov; Semion V Petrov; Roman N Kulagin
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

2.  Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years.

Authors:  N Ando; S Ozawa; Y Kitagawa; Y Shinozawa; M Kitajima
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

3.  Guidelines for the management of oesophageal and gastric cancer.

Authors:  W H Allum; S M Griffin; A Watson; D Colin-Jones
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

Review 4.  [R1 resection in the surgery of upper gastrointestinal tumors: relevance and therapeutic consequences].

Authors:  F Lordick; K Ott; A Novotny; C Schuhmacher; J R Siewert
Journal:  Chirurg       Date:  2007-09       Impact factor: 0.955

5.  [Neoadjuvant therapy for squamous cell carcinoma of the esophagus].

Authors:  F Lordick
Journal:  Chirurg       Date:  2005-11       Impact factor: 0.955

6.  Surgical management of esophageal carcinoma.

Authors:  Amit N Patel; John T Preskitt; Joseph A Kuhn; Robert F Hebeler; Richard E Wood; Harold C Urschel
Journal:  Proc (Bayl Univ Med Cent)       Date:  2003-07

7.  Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus.

Authors:  Nasser Altorki; Michael Kent; Cathy Ferrara; Jeffrey Port
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

Review 8.  Multimodal treatment for squamous cell esophageal cancer.

Authors:  U Fink; H J Stein; H Wilke; J D Roder; J R Siewert
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

9.  Long-term outcomes and prognostic factors for patients with esophageal cancer following radiotherapy.

Authors:  Chuang-Zhen Chen; Jian-Zhou Chen; De-Rui Li; Zhi-Xiong Lin; Ming-Zhen Zhou; Dong-Sheng Li; Zhi-Jian Chen
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

10.  Prediction of hematogenous recurrence in patients with esophageal carcinoma.

Authors:  Hiroyuki Kato; Tatsuya Miyazaki; Masanobu Nakajima; Makoto Sohda; Yasuyuki Fukai; Norihiro Masuda; Minoru Fukuchi; Ryokuhei Manda; Katsuhiko Tsukada; Hiroyuki Kuwano
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.